A recent paper discovered that TAMs secrete IL-6 in the TME to stimulate protein arginine methyltransferase 1 (PRMT1)-mediated meR342-EZH2 formation in order to stabilize the enhancer of Zeste Homolog 2 (EZH2) in breast cancer cells. Here, EZH2 is linked to breast carcinoma.